Why is Indo US Bio-Tech falling/rising?

As of 08-Aug, Indo US Bio-Tech Ltd is experiencing a decline in its stock price, currently at Rs 168.75, which reflects a decrease of Rs 5.25 or 3.02%. The stock has underperformed its sector by 1.36% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 6.07% during this period. Additionally, the stock has touched an intraday low of Rs 164.6, indicating significant selling pressure. Over the past week, the stock has shown a slight decline of 0.38%, while its performance over the last month has been more favorable, with a gain of 10.98%. However, year-to-date, the stock is down 46.43%, suggesting ongoing challenges. Notably, there has been a rise in investor participation, with delivery volume increasing by 63.09% against the 5-day average, which may indicate some interest despite the current price decline.
In the broader market context, the Sensex has also faced challenges, with a decline of 0.92% over the past week and a more modest drop of 4.60% over the last month. This suggests that while Indo US Bio-Tech is underperforming, it is not alone in facing headwinds, as the overall market has been struggling as well. The stock's performance relative to the benchmark indicates that it has not been able to capitalize on the broader market trends, especially given its significant year-to-date decline compared to the Sensex's modest gain of 2.20%. The liquidity of the stock remains adequate for trading, which may provide some support, but the prevailing negative sentiment and recent price movements suggest that investors are cautious at this time.